• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Novo

GLP-1 obesity drug autoinjector obesity
Pharma

How drugmakers can capitalize on the GLP-1 'consumer overlay'

Social media buzz and the rise of compounding have reshaped how many patients seek out GLP-1 drugs.
Fraiser Kansteiner Oct 7, 2026 10:00am
yellow traffic light

Novo cites production site corrections amid hemophilia FDA delay

Oct 5, 2026 7:15am
Asia

AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia

Oct 2, 2026 9:35am
Conceptual illustration of layoffs featuring rows of translucent human figures overlaid with large blue scissors symbolizing

Novo is handing out pink slips to 108 staffers in New Jersey

Sep 30, 2026 2:26pm
locking horns

Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan

Sep 29, 2026 11:20am
Lilly

Lilly nabs weekly insulin nod from FDA in new challenge to Novo

Sep 25, 2026 8:57am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings